Contribution of vascular risk factors to the progression in Alzheimer disease
about
Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical CenterCerebrovascular disease in ageing and Alzheimer's diseasePathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesisStatins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory studyDomains of cognitive function in early old age: which ones are predicted by pre-retirement psychosocial work characteristics?Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease.3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjectsThe impact of vascular comorbidities on qualitative error analysis of executive impairment in Alzheimer's diseaseLong-term cognitive and psychological outcomes in the awakening and breathing controlled trial.Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors.Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and microbleeds.Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease.A turning point for Alzheimer's disease?The association of traumatic brain injury with rate of progression of cognitive and functional impairment in a population-based cohort of Alzheimer's disease: the Cache County Dementia Progression StudyDiet-induced obesity and low testosterone increase neuroinflammation and impair neural functionOctodon degus: a strong attractor for Alzheimer research.The overlap between neurodegenerative and vascular factors in the pathogenesis of dementiaThe overlap between vascular disease and Alzheimer's disease--lessons from pathology.Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's diseaseCardiovascular prevention of cognitive decline.The relationship between cortical blood flow and sub-cortical white-matter health across the adult age span.Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's diseaseBioAge: toward a multi-determined, mechanistic account of cognitive aging.Effects of aerobic exercise on mild cognitive impairment: a controlled trialVascular basis for brain degeneration: faltering controls and risk factors for dementia.Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotesNeurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models.Brain aging and dementia during the transition from late adulthood to old age: design and methodology of the "Invece.Ab" population-based study.Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.A kernel machine method for detecting effects of interaction between multidimensional variable sets: an imaging genetics application.Interaction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's diseaseHemodynamic effects of combined focal cerebral ischemia and amyloid protein toxicity in a rat model: a functional CT studyObesity is linked with lower brain volume in 700 AD and MCI patientsA Longitudinal SPECT Study of Different Patterns of Regional Cerebral Blood Flow in Alzheimer's Disease with or without DiabetesMeasurement of cerebral microvascular compliance in a model of atherosclerosis with optical coherence tomography.Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies.Cerebrovascular lesions induce transient β-amyloid deposition.Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations.Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles
P2860
Q24563891-7676B02D-44A6-4609-A8B9-5F63EC64074EQ26771852-BE245CE0-23BA-43FF-B23A-C239DEA465FDQ30235369-0E386686-67F0-4892-A054-1A940DD6762DQ30417962-7E65CAC1-8844-4D05-A121-4707061AC68DQ33676461-49EC6F8E-CAD7-48AE-B426-98CE52D0D54FQ33745920-1D12301A-970E-49E8-AEC7-608129CED437Q33990243-806550CC-0CB6-41A1-8909-E2D4DE3940D2Q34011851-DC68EA8A-77BA-4938-B3CF-591B4315BD2DQ34032859-4881422E-5283-43EE-BDD8-3969C8966117Q34047968-B02DEC55-A5E8-4ADC-B2FF-D6547F1A6E5DQ34149357-1C36B5D6-7BE0-445F-BC39-5AE581E15D8CQ34154473-A3AB0660-F242-4149-AE3B-11110DAE4A35Q34197623-87F02E9E-1BEE-4CF7-B69C-CF5E3BAA8CDCQ34269094-852C8791-4F23-4A06-B76A-867995AFDB5BQ34309465-EC2271BB-5A0B-4502-8923-B8758E11AAF8Q34368025-74F73530-E73E-4381-96E7-698012BBE88DQ34402033-71AEE9AA-FC7D-4389-B16F-94D1765C4D6CQ34484708-26DA384E-2502-4B3D-97A9-C8EAF6C54BDEQ34533985-CC8F2B11-9DF0-4669-A271-FC5ACB4C38B5Q34557674-3D39BCED-7B5C-441F-96A2-A4025C2E2D67Q34599407-A9D56269-5F17-4917-A0C1-E1BCD6486448Q34626031-FBAE8E4A-E5AC-48D6-B000-03E1357B8C54Q34644175-9F725501-1AAB-42AA-B024-1C0F5FD7F373Q34666688-D796EB3F-6C1D-488C-9929-E2B8DD6F0596Q34680483-2E15F1C7-E3DB-4AC6-8196-BF22C89C7065Q34743183-80F8C39E-F3D8-4AFC-B6F6-A640827559B5Q34774194-76A2B3BE-0E07-4E31-AEFA-65A3A5DCEB83Q34788958-BDCBF46D-3A7F-47B1-B504-48224001DC07Q34996345-92CFFA12-6984-4012-A867-80C1AB42C59EQ35031724-07DD4C71-9556-4C38-A9E8-C1CCDB967E39Q35117929-EC0CAF26-9590-4F5B-A9F9-A4016FE8C5CBQ35189449-8678A845-FFE5-40F2-86A2-2EF698BF5777Q35196415-DCFEFA49-3F7E-4724-895C-CD2AD2794943Q35401263-43A4D659-88E0-4DA6-920B-35043A2BC309Q35428133-D5CA23BD-F820-4B65-BA47-2F78AAB1E618Q35515237-580BFA4A-CA94-43DC-86D2-0B806ECF458AQ35536228-108B6EAC-0F9C-410F-B70B-344C01D15FF4Q35606745-2D11BE1C-79DA-4A56-B0A6-6336052F5BB3Q35642416-4BA6577C-26E3-4C6E-8536-1753EDB32897Q35700985-FAFDA995-7C83-4A66-9DF3-398A38FB27BF
P2860
Contribution of vascular risk factors to the progression in Alzheimer disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Contribution of vascular risk factors to the progression in Alzheimer disease
@ast
Contribution of vascular risk factors to the progression in Alzheimer disease
@en
type
label
Contribution of vascular risk factors to the progression in Alzheimer disease
@ast
Contribution of vascular risk factors to the progression in Alzheimer disease
@en
prefLabel
Contribution of vascular risk factors to the progression in Alzheimer disease
@ast
Contribution of vascular risk factors to the progression in Alzheimer disease
@en
P2093
P2860
P1433
P1476
Contribution of vascular risk factors to the progression in Alzheimer disease
@en
P2093
Adam M Brickman
Elizabeth P Helzner
José A Luchsinger
M Maria Glymour
Nikolaos Scarmeas
Stephanie Cosentino
P2860
P304
P356
10.1001/ARCHNEUR.66.3.343
P50
P577
2009-03-01T00:00:00Z